使用基于KPLS的QSAR分析识别对JNK3酶抑制负责的药
Ravi Kumar Rajan1, Maida Engels2, Umaa Kuppuswamy2
1Department of Pharmacology, Himalayan Pharmacy Institute, Majitar, Sikkim-737136, India.
Central nervous system agents in medicinal chemistry
|March 4, 2025
概括
这项研究确定了强大的c-Jun N-终端激酶3 (JNK3) 抑制剂的关键结构特征. 固体效应和特定的替代物,如氧和,显著影响JNK3抑制活性.
科学领域:
- 药用化学 医学化学
- 计算化学的计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药理方法利用化学功能和空间形状来增强目标受体功率.
- c-Jun N-终端酶3 (JNK3) 是中枢神经系统 (CNS) 中的一个关键蛋白酶.
研究的目的:
- 开发一种可预测的2D QSAR模型,用于识别负责JNK3抑制的药.
- 为了指导强效和选择性JNK3抑制剂的设计.
主要方法:
- 使用基于内核的部分最小平方 (KPLS) 方法进行2D QSAR建模.
- 从现有的文献中编制了一个小分子JNK3抑制剂库.
- 采用Canvas 2.6软件用于预测模型开发.
主要成果:
- 确定了二次胺和甲基组作为JNK3抑制的有利贡献者.
- 固体效应,特别是像t-丁这样的大型组,对活动产生了负面影响.
- 诸如基,甲基和等替代物对功效产生了积极的影响,而三级和甲基组则对功效产生了不利影响.
- 终端异环环 (例如,pyrimidinyl acetonitrile) 增强了活性,而某些和piperazine修饰是不利的.
结论:
- 替代效应,特别是环上的硬质因子,对于JNK3抑制剂活性至关重要.
- 不被替代的硫胺和尿素部分的自由对于最佳的JNK3抑制至关重要.
- 了解固态,电子和定位影响有助于设计更有选择性的JNK3抑制剂.
关键词:
在IC50.50.IC50.IC50. IC50.在JNK3中,JNK3是最常见的.在KPLS中获得KPLS.在QSAR中使用QSAR.画布 2.6 画布 2.6 画布作为一个药物学家,他做了一些药物学.更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
01:28Structure-Activity Relationships and Drug Design
480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480